5000th patient treated with protons for eye tumours
From the patient's perspective at the treatment station: The proton beam is directed through the hole in the shield onto the tumour in the eye. The brass shield is adjusted to the individual tumour size and protects the surrounding tissue. © HZB/. S. Kodalle
The treatment centre for eye tumour therapy in Berlin-Wannsee © HZB/ S. Kodalle
For more than 25 years, Charité – Universitätsmedizin Berlin and the Helmholtz-Zentrum Berlin (HZB) have been jointly offering proton radiation therapy for eye tumours. The HZB operates a proton accelerator in Berlin-Wannsee for this purpose, while Charité provides medical care for the patients. The 5000th patient was treated at the beginning of August.
The treatment room and proton accelerator are specially adapted to the requirements for optimal and highly precise treatment of tumours inside the eye and are unique in this combination. The largest group of tumours in the eye is the rare and malignant uveal melanoma, which, as the name suggests, develops in the uvea of the eye.
Proton therapy is used as an effective method of fighting tumours, often as an alternative to removing the eye, with the aim of preserving the eye and its function as much as possible. The protons can be directed very precisely at the tumour, sparing the surrounding healthy tissue. Compared to other radiation methods, proton therapy causes less damage to the cornea, lens, retina and optic nerve in many cases.
8 August 2025 was a special day: it was the day on which the 5000th patient completed their eye tumour treatment. This makes the Berlin experts one of the world's leading centres: together, the two institutions (Charité and HZB) have treated 10 percent of all eye tumours treated with protons worldwide. The cooperation with Charité – Universitätsmedizin Berlin also opens up prospects for the further development of proton therapy in order to carry out even more precise and effective treatments in the future – for the benefit of patients.
- Science in Berlin: collaborative, diverse, innovative, internationalScience is a key social and economic factor for Berlin. It creates jobs and adds value, attracts talent from all over the world, and enriches city life. To ensure that Berlin remains one of the world’s leading centres of science in the future, science must feature even more prominently on the political agenda. This is what BR50 stands for: over 50 non-university research institutions, including the HZB, are joining forces in this network. Following the election in Berlin, BR50 is now addressing politicians with a position paper, accompanied by the campaign “𝗪𝗶𝗿 𝗳𝗼𝗿𝘀𝗰𝗵𝗲𝗻 𝗳ü𝗿 𝗕𝗲𝗿𝗹𝗶𝗻.”
- Does African Architecture exist?The world’s first Pan-African Architecture Biennale took place this September in Nairobi, Kenya. People from the worlds of architecture, art, academia and politics from 54 African countries and the diaspora had travelled to Nairobi to exchange ideas on traditional and contemporary building methods, materials, experiences and projects. Samira Aden co-organised this biennial as lead curator. We spoke to her about it.
- Nanosilver as an electrocatalyst for CO₂ reductionVia electrolysis, CO2 can be reduced to CO, a raw material for further chemical products such as fuels. Within the GreenQuest Project, an internation team led by HZB chemist Prashanth Menezes has now systematically investigated catalyst layers made of silver nanoparticles, varying both the size of the particles and their density. The best yield was achieved with nanoparticles with diameters of around 10 nm, which were loosely distributed. Furthermore, they demonstrated how the economic efficiency of the electrochemical cell can be enhanced by integrating an additional chemical reaction at the anode, enabling the simultaneous production of a valuable formic acid, hydrogen, and CO in one device.